Premium
Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange
Author(s) -
Sullivan Matthew R.,
Danilov Alexey V.,
Lansigan Frederick,
Dunbar Nancy M.
Publication year - 2015
Publication title -
journal of clinical apheresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.697
H-Index - 46
eISSN - 1098-1101
pISSN - 0733-2459
DOI - 10.1002/jca.21371
Subject(s) - medicine , thrombotic microangiopathy , therapeutic plasma exchange , carfilzomib , pharmacology , intensive care medicine , multiple myeloma , proteasome inhibitor , disease
Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma. J. Clin. Apheresis, 2014. © 2014 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom